Published in Biochemistry (Mosc) on May 01, 1999
New feature of angiotensin-converting enzyme: carbohydrate-recognizing domain. J Mol Recognit (2000) 0.81
[Immunomodulating effects of alpha1-acid glycoprotein (orosomucoid) in cultured human peripheral blood lymphocytes]. Biull Eksp Biol Med (1994) 0.80
[Molecular forms of alpha-1-acid glycoprotein in human blood serum. Differences in levels of di-, tri-, and tetra-antennary N-linked carbohydrate chains]. Bioorg Khim (1991) 0.80
[Conjugates and carbohydrate chains of alpha 1-acid glycoprotein with polyacrylamide maintain the immunomodulating activity of native glycoprotein]. Bioorg Khim (1995) 0.80
[Madecassol treatment of systemic and localized scleroderma]. Ter Arkh (1998) 0.79
[Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases]. Ter Arkh (1994) 0.78
Albumin-like glycoprotein from human fetal tissue. Biochem Mol Biol Int (1994) 0.78
[Fluorescent derivatives of carbohydrates in the analysis of the structure of glycoconjugates. N-(4-methylcoumarin-7-yl) glycamines in the study of asparagine-bound carbohydrate chains of glycoproteins]. Bioorg Khim (1987) 0.77
Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol (1997) 0.77
[Clinical associations of C-reactive protein in systemic sclerosis]. Ter Arkh (2006) 0.77
[Familial systemic scleroderma: a follow-up study of concordant monozygotic twins]. Ter Arkh (1981) 0.76
[Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Ter Arkh (2004) 0.76
[The assessment of left ventricular diastolic function in patients with systemic scleroderma by radionuclide ventriculography]. Ter Arkh (1995) 0.76
[Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma]. Revmatologiia (Mosk) (1991) 0.76
[Clinico-immunological heterogeneity of idiopathic inflammatory myopathy]. Klin Med (Mosk) (1995) 0.75
[The role of sympathetic reactivity in the development of Raynaud's syndrome]. Ter Arkh (1993) 0.75
Microcirculation disorders in systemic connective tissue diseases. Bibl Anat (1975) 0.75
[Cross syndromes between systemic scleroderma and other connective tissue diseases]. Ter Arkh (1974) 0.75
[Correction of microcirculatory disorders in rheumatic diseases]. Ter Arkh (1985) 0.75
[X-ray characteristics of esophageal involvement in systemic scleroderma]. Vestn Rentgenol Radiol (1973) 0.75
[Treatment of Raynaud's syndrome with calcium entry blockers]. Ter Arkh (1987) 0.75
[The action of electroacupuncture with the use of the omega potential on the general condition and work capacity of students]. Vrach Delo (1991) 0.75
[Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis]. Klin Med (Mosk) (1986) 0.75
[Raynaud's disease as a manifestation of generalized vascular disorders in systemic scleroderma]. Kardiologiia (1973) 0.75
[The clinical heterogeneity of the scleroderma group of diseases]. Ter Arkh (1992) 0.75
[The vasoprostan treatment of patients with Raynaud's syndrome]. Ter Arkh (1997) 0.75
[Clinical significance of anti-Ro and anti-La antigen antibodies in Sjögren's disease and syndrome]. Ter Arkh (1988) 0.75
[Sclerodermic kidney]. Ter Arkh (1981) 0.75
[Myocardial scintigraphy with thallium-201 in the diagnosis of cardiac involvement in systemic scleroderma]. Ter Arkh (1995) 0.75
[Clinical evaluation of the determination of blood serum and urinary glycosaminoglycans in systemic scleroderma]. Ter Arkh (1984) 0.75
[Antibodies to DNA and deoxynucleoprotein in Sjögren's disease and syndrome]. Ter Arkh (1990) 0.75
[Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy]. Klin Med (Mosk) (1997) 0.75
[The local therapy of systemic scleroderma]. Ter Arkh (1990) 0.75
[Cellular immune response to collagen I in patients with systemic scleroderma]. Vopr Revm (1982) 0.75
[Certain data on the cytochemistry of the peripheral blood lymphocytes in scleroderma]. Sov Med (1973) 0.75
[Etiology and pathogenesis of systemic scleroderma]. Revmatologiia (Mosk) (1983) 0.75
[Eosinophilia-myalgia syndrome in rheumatology]. Klin Med (Mosk) (1994) 0.75
[Clinical aspects and diagnosis of diffuse eosinophilic fasciitis]. Ter Arkh (1986) 0.75
[Ultrastructure of the skin in systemic scleroderma]. Arkh Patol (1975) 0.75
[Multifocal fibrosis (localized systemic sclerosis)]. Klin Med (Mosk) (1992) 0.75
[New markers of collagen and basal membrane metabolism and kidney involvement in systemic scleroderma]. Ter Arkh (1990) 0.75
Microangiopathy and microcirculatory disorders in progressive systemic sclerosis (PSS). Bibl Anat (1973) 0.75
[Modern therapeutic methods in Raynaud's syndrome]. Ter Arkh (1990) 0.75
[Antibodies reacting with epithelial cells of the thymus and skin in the sera of patients with rheumatism and erysipelas]. Vestn Akad Med Nauk SSSR (1986) 0.75
[Antibodies to Ro(SSA) and La(SSB) antigens in Sjögren's disease and syndrome]. Revmatologiia (Mosk) (1987) 0.75
[Effect of rheopolyglucin on microcirculation function in systemic scleroderma]. Revmatologiia (Mosk) (1984) 0.75
[Intestinal disorders in systemic scleroderma]. Ter Arkh (1972) 0.75
[Pseudosclerodermic conditions]. Ter Arkh (1976) 0.75
[Treatment of systemic scleroderma with D-penicillin]. Ter Arkh (1977) 0.75
[A working classification and nomenclature of rheumatic diseases (pediatric aspects)]. Pediatriia (1989) 0.75
[Analysis of the distribution of class I HLA-antigens in patients with systemic scleroderma with regard to features of the clinical course of the disease and therapy with D-penicillamine]. Genetika (1989) 0.75
Cyclic nucleotides and calcium transport in cultured dermal fibroblasts from progressive systemic sclerosis and rheumatoid arthritis patients. Arthritis Rheum (1984) 0.75
[Systemic scleroderma and pregnancy]. Revmatologiia (Mosk) (1985) 0.75
[Cytotoxic antibodies to thymocyte antigens in rheumatism and other diseases]. Biull Eksp Biol Med (1985) 0.75
[Clinico-morphological characteristics and working classification of kidney diseases in patients with systemic scleroderma]. Ter Arkh (1985) 0.75
[Heterogeneity of the immune response to antigens of the muscular and interstitial connective tissue of the heart in patients with rheumatic diseases. I. Age factors and specificity to alpha-galactose]. Vestn Akad Med Nauk SSSR (1989) 0.75
[The evolution of the concepts of systemic scleroderma]. Ter Arkh (1995) 0.75
[Articular syndrome at early stages of rheumatoid arthritis, systemic scleroderma and infectious-allergic syndrome]. Sov Med (1977) 0.75
[The sclerodermatous group of diseases]. Ter Arkh (1987) 0.75
[Survival and prognostic significance of a kidney lesion in systemic scleroderma]. Ter Arkh (1982) 0.75
[The current strategy for pathogenetic therapy in systemic scleroderma]. Ter Arkh (1997) 0.75
[Induced scleroderma]. Revmatologiia (Mosk) (1991) 0.75
[Eosinophilic fasciitis (Shulman's syndrome)]. Revmatologiia (Mosk) (1991) 0.75
[Differential diagnosis of diffuse eosinophilic fasciitis]. Revmatologiia (Mosk) (1990) 0.75
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)]. Ter Arkh (1985) 0.75
[Multifocal fibrosis]. Klin Med (Mosk) (1995) 0.75
[Selective lymphapheresis (a method for the selective elimination of cellular elements and fibronectin complexes from the lymph) in systemic scleroderma]. Ter Arkh (1992) 0.75
[The ideas of M. P. Konchalovskiĭ in modern rheumatology]. Klin Med (Mosk) (1986) 0.75
[Destructive disease of the lungs with the formation of gigantic cysts and cavities in systemic scleroderma]. Ter Arkh (1972) 0.75
[Antinuclear antibodies in Sjögren's disease and syndrome]. Ter Arkh (1986) 0.75
[Roentgenocinematography in diagnosis of cardiac lesion in systemic scleroderma]. Ter Arkh (1976) 0.75
[Diffuse connective tissue diseases and malignant tumors]. Klin Med (Mosk) (1985) 0.75
[Significance of microcirculatory disorders in various rheumatic diseases]. Revmatologiia (Mosk) (1986) 0.75
[Disorders of the microcirculation in systemic scleroderma]. Kardiologiia (1974) 0.75
[The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma]. Ter Arkh (1992) 0.75
[Clinical variants of early stages of systemic scleroderma]. Ter Arkh (1975) 0.75
[The use of Capoten in systemic scleroderma]. Ter Arkh (1992) 0.75
[Characteristics of collagen protein biosynthesis in fibroblast cultures from the skin of patients with systemic scleroderma]. Vopr Revm (1982) 0.75
[Clinico-roentgenological examination of the esophagus at different stages of systemic scleroderma]. Sov Med (1974) 0.75
[Working classification and nomenclature of rheumatic diseases]. Revmatologiia (Mosk) (1989) 0.75
[Pathogenetic mechanisms of microcirculation disorders in rheumatoid diseases]. Ter Arkh (1983) 0.75
[The clinical value of determining beta-glucuronidase activity in the cells and blood serum of patients with systemic scleroderma]. Revmatologiia (Mosk) (1990) 0.75
[Aggregation properties of thrombocytes in systemic diseases of the connective tissue]. Sov Med (1977) 0.75
[Pseudosclerodermal paraneoplastic syndrome]. Ter Arkh (1984) 0.75
[Myocardial tomoscintigraphy with 201Tl in the diagnosis of cardiac involvement in systemic scleroderma]. Ter Arkh (1996) 0.75
[Working classification and nomenclature of rheumatic diseases (1985)]. Revmatologiia (Mosk) (1986) 0.75
[Effect of epinephrine on a culture of normal skin fibroblasts and fibroblasts in systemic scleroderma]. Vopr Med Khim (1983) 0.75
[Current pathogenetic therapy of systemic scleroderma]. Revmatologiia (Mosk) (1987) 0.75
[Antiendothelial antibodies in systemic scleroderma and Raynaud's disease]. Ter Arkh (1995) 0.75
[Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]. Ter Arkh (1985) 0.75
[Diffuse eosinophilic fasciitis]. Klin Med (Mosk) (1987) 0.75
[Transcapillary metabolic disorders in systemic diseases of the connective tissue]. Vopr Revm (1977) 0.75
[Raynaud syndrome: pathophysiologic mechanisms, diagnosis, treatment]. Revmatologiia (Mosk) (1986) 0.75
[Use of magnetotherapy in the overall treatment of peptic ulcer]. Vrach Delo (1979) 0.75
[Disorders of the heart rhythm and conductivity in patients with systemic scleroderma based on the data from 24-hour ECG monitoring and from the transesophageal electrical stimulation of the left atrium]. Revmatologiia (Mosk) (1992) 0.75
[Plasma renin activity in patients with systemic scleroderma and renal lesions]. Ter Arkh (1984) 0.75
[Microcirculatory disorders in the genesis of sclerodermic nephropathy]. Ter Arkh (1986) 0.75
[Echocardiographic study of heart function in systemic scleroderma]. Ter Arkh (1986) 0.75
[Sjögren's syndrome in systemic scleroderma]. Ter Arkh (1988) 0.75